Resources

Selected
  • Systematic reviews (SYSVAC)
  • Pregnant women
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

264 results found

2024 ∙ Rahbeni, T. A. Satapathy, P. Itumalla, R. Marzo, R. R. Mugheed, K. A. L. Khatib, M. N. Gaidhane, S. Zahiruddin, Q. S. Rabaan, A. A. Alrasheed, H. A. Al-Subaie, M. F. Al Kaabil, N. A. Alissa, M. Ibrahim, Aaal Alsaif, H. A. Naser, I. H. Rustagi, S. Kukreti, N. Dziedzic, A.

COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis

  • All age groups
  • Healthcare workers
  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Ghafari, Z. Khameneh, A. Vahedi, L.

COVID19 Vaccination Considerations for Pregnant Women: A Systematic Review

  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Davies, H. G. Thorley, E. V. Al-Bahadili, R. Sutton, N. Burt, J. Hookham, L. Karampatsas, K. Lambach, P. Muñoz, F. Cutland, C. L. Omer, S. Le Doare, K.

Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review

  • Pregnant women
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Zhang, J. Lian, Z. Xue, X. Li, J. Zhu, Y. Huang, N. Xie, W.

Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination

  • All age groups
  • Pregnant women
  • Human papillomavirus (HPV)
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Kaur, H. Chauhan, A. Mascarenhas, M.

Does SARS Cov-2 infection affect the IVF outcome - A systematic review and meta-analysis

  • All age groups
  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Fernández-García, S. Del Campo-Albendea, L. Sambamoorthi, D. Sheikh, J. Lau, K. Osei-Lah, N. Ramkumar, A. Naidu, H. Stoney, N. Sundaram, P. Sengupta, P. Mehta, S. Attarde, S. Maddock, S. Manning, M. Meherally, Z. Ansari, K. Lawson, H. Yap, M. Kew, T. Punnoose, A. Knight, C. Sadeqa, E. Cherian, J. Ravi, S. Chen, W. Walker, K. O'Donoghue, K. van Wely, M. van Leeuwen, E. Kostova, E. Kunst, H. Khalil, A. Brizuela, V. Kara, E. Kim, C. R. Thorson, A. Oladapo, O. T. Mofenson, L. Gottlieb, S. L. Bonet, M. Moss, N. Zamora, J. Allotey, J. Thangaratinam, S. Preg, C. O. V. Living Systematic Review Consortium

Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Santimano, A. J. Al-Zoubi, R. M. Al-Qudimat, A. R. Al Darwish, M. B. Ojha, L. K. Rejeb, M. A. Hamad, Y. Elrashid, M. A. Ruxshan, N. M. El Omri, A. Bawadi, H. Al-Asmakh, M. Yassin, A. Aboumarzouk, O. M. Zarour, A. Al-Ansari, A. A.

Efficacy and Clinical Outcomes of mRNA COVID-19 Vaccine in Pregnancy: A Systematic Review and Meta-analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Zeng, B. Liu, X. Yang, Q. Wang, J. Ren, Q. Sun, F.

Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Pang, Y. Lu, H. Cao, D. Zhu, X. Long, Q. Tian, F. Long, X. Li, Y.

Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis

  • Adults
  • Older adults
  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Wu, Y. Bai, Y. Zhu, B. Chang, F. Lu, Y.

Efficacy, Safety, and Immunogenicity of Subunit Respiratory Syncytial Virus Vaccines: Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Pregnant women
  • Adults
  • Older adults
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Moderate
Loading...